Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02766699
Title A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent Glioblastoma Multiforme (GBM) (CerebralEDV)
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Engeneic Pty Limited
Indications

glioblastoma

Therapies

EGFR(V)-EDV-Dox

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.